Frequency News and Research

RSS

Physicists find clues to origin, evolution of wrinkles in thin sheets

As a sign of aging or in a suit, wrinkles are almost never welcome, but two papers in the current issue of Physical Review Letters offer some perspective on what determines their size and shape in soft materials.

16 Jul 2010

Research supports population screening for fragile X syndrome in women of reproductive age

There's adequate research data to support population screening of women of childbearing age for fragile X syndrome—the most common inherited cause of cognitive impairment, according to a report in the July issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

14 Jul 2010

Highlights of AAPM 52nd meeting

The 52nd meeting of the American Association of Physicists in Medicine (AAPM) convenes from July 18 - 22, 2010 in Philadelphia, PA.

14 Jul 2010

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms

GE Healthcare Medical Diagnostics today announced the market reintroduction of Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in select echocardiograms. Optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders. The safety and efficacy of Optison with exercise stress or pharmacologic stress testing have not been established.

12 Jul 2010

Study results show cognitive decline significantly lower among regular tea drinkers

Results of a new study found people age 65 or older who drank tea regularly had 17-37% less cognitive decline compared with people who did not drink tea. The new findings were presented here at the Alzheimer's Association's International Conference on Alzheimer's Disease 2010.

12 Jul 2010

Simple interventions by pediatricians change parent's perspective about child being overweight or obese

Some simple interventions used by pediatricians were enough to change a parent's perspective about a child's being overweight or obese, and change the parent's behaviors at home to reduce those risks.

12 Jul 2010

Biogen Idec, Swedish Orphan Biovitrum present results from rFIXFc Phase 1/2a study in hemophilia B

Biogen Idec and Swedish Orphan Biovitrum AB today announced results from a Phase 1/2a open-label, dose-escalation, safety and pharmacokinetic study of the companies' long-lasting, fully-recombinant factor IX Fc fusion protein (rFIXFc) in hemophilia B patients. The data, which were presented at the World Federation of Hemophilia Congress in Buenos Aires, Argentina, on July 11, 2010, showed that rFIXFc was well tolerated and demonstrated an approximately three-fold increase in half-life compared to historical data for existing therapies.

12 Jul 2010

Drosophila fly study may aid in staving off diseases in humans using defensive bacteria

It has been a basic principle of evolution for more than a century that plants and animals can adapt genetically in ways that help them better survive and reproduce.

12 Jul 2010

Biogen Idec, Swedish Orphan Biovitrum announce advancement of rFVIIIFc into registrational study

Biogen Idec and Swedish Orphan Biovitrum today announced that they plan to advance the companies' long-lasting, fully-recombinant factor VIII Fc fusion protein (rFVIIIFc) into a registrational clinical trial in people with hemophilia A. The decision to advance the program is based on promising data from a Phase 1/2a open-label, cross-over, multi-center, dose-escalation study that evaluated the safety and pharmacokinetics of an intravenous injection of rFVIIIFc in 16 previously-treated patients with severe hemophilia A.

12 Jul 2010

Studies support association of physical activity, diet with maintaining cognitive ability, reducing dementia risk

Evidence from three long-term, large-scale studies supports the association of physical activity and certain dietary elements (tea, vitamin D) with possibly maintaining cognitive ability and reducing dementia risk in older adults, according to new research presented today at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 in Honolulu, HI.

12 Jul 2010

Study shows association between obesity and GERD in children

Extremely obese children have a 40 percent higher risk of gastroesophageal reflux disease and children who are moderately obese have a 30 percent higher risk of GERD compared to normal weight children, according to a Kaiser Permanente study published online in the International Journal of Pediatric Obesity.

9 Jul 2010

Allergan receives UK MHRA authorisation of BOTOX for prophylaxis of headache in chronic migraine

Allergan is pleased to announce that BOTOX® (botulinum toxin type A) has been licensed by the MHRA in the UK for the prophylaxis of headaches in adults who have chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine). This is the first licence worldwide of BOTOX® for this indication, and is also the first prophylactic (preventative) treatment to receive a specific licence for patients with chronic migraine.

9 Jul 2010

NeuroPace submits PMA to FDA for world's first responsive neurostimulation system

NeuroPace, Inc. today announced that it has submitted its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its RNS® System, a novel investigational device that utilizes responsive neurostimulation to monitor and interrupt abnormal electrical activity in the brain before seizures occur. The PMA application is for an indication to treat people with medically refractory partial onset epilepsy originating from one or two locations in the brain.

9 Jul 2010

Health information technology still faces significant barriers to implementation: Survey

Hospitals understand the importance of health information technology (IT) and the benefits of its widespread adoption, yet as a field still face significant barriers to implementation according to a newly released survey of America's Most Wired hospitals and health systems.

8 Jul 2010

Nymox reports positive new results from pooled analysis of NX-1207 clinical trials for BPH

Nymox Pharmaceutical Corporation reported today positive new results from pooled analysis of completed clinical trials of NX-1207, the Company's investigational drug for BPH. The trial data shows that patients receiving NX-1207 recorded significant quantitative improvement in the important symptom of urgent need to urinate.

8 Jul 2010

GSK, XenoPort disappointed with GSK1838262/XP13512 phase 2b study for migraine headaches

GlaxoSmithKline and XenoPort, Inc. announced today that GSK1838262/XP13512 (gabapentin enacarbil) did not demonstrate a statistically significant improvement compared to placebo as a prophylactic treatment for migraine headaches. This phase 2b dose-ranging study evaluated the efficacy, safety and tolerability of GSK1838262 in adults diagnosed with migraine headache (with or without aura) according to the International Headache Society criteria.

8 Jul 2010

Study finds decline in homicide, suicide rates among mentally ill people

People with mental health problems are committing fewer homicides while the number of suicides by mental health patients has also fallen, latest figures reveal; a previous rise in homicides by mentally ill people may have been the result of drug misuse, says the report.

7 Jul 2010

Crux Biomedical commences enrollment in Retrieve 2 pivotal U.S. IDE trial of new Vena Cava Filter

Crux Biomedical®Inc. announced today that it has successfully enrolled the first patient in its Retrieve 2 pivotal U.S. IDE trial. The trial will evaluate the safety and efficacy of Crux's new Vena Cava Filter (VCF). The Crux VCF is a retrievable, implantable filter which is designed to trap blood clots that can lead to a potentially fatal pulmonary embolism (PE). It is the first VCF to be developed that is bidirectional and thus permits insertion or retrieval from either the femoral or jugular veins.

7 Jul 2010

Debate over the ill effects of wind turbines on health

The National Health and Medical Research Council (NHMRC) studied the purported ill effects of the wind turbines on health before reporting that there was no evidence that the turbines' low frequency noise or shadow flicker made people ill.

6 Jul 2010

Children see more fast food TV ads and fewer sweets and beverage ads: Study

Children saw fewer television advertisements for certain foods, including those for sweets and beverages, in 2007 compared with 2003, according to a report posted online today that will appear in the September print issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals. However, children now see more fast-food ads, and racial gaps in exposure to all food advertising have increased.

6 Jul 2010

Frequency News and Research

Physicists find clues to origin, evolution of wrinkles in thin sheets

Research supports population screening for fragile X syndrome in women of reproductive age

Highlights of AAPM 52nd meeting

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms

Study results show cognitive decline significantly lower among regular tea drinkers

Simple interventions by pediatricians change parent's perspective about child being overweight or obese

Biogen Idec, Swedish Orphan Biovitrum present results from rFIXFc Phase 1/2a study in hemophilia B

Drosophila fly study may aid in staving off diseases in humans using defensive bacteria

Biogen Idec, Swedish Orphan Biovitrum announce advancement of rFVIIIFc into registrational study

Studies support association of physical activity, diet with maintaining cognitive ability, reducing dementia risk

Study shows association between obesity and GERD in children

Allergan receives UK MHRA authorisation of BOTOX for prophylaxis of headache in chronic migraine

NeuroPace submits PMA to FDA for world's first responsive neurostimulation system

Health information technology still faces significant barriers to implementation: Survey

Nymox reports positive new results from pooled analysis of NX-1207 clinical trials for BPH

GSK, XenoPort disappointed with GSK1838262/XP13512 phase 2b study for migraine headaches

Study finds decline in homicide, suicide rates among mentally ill people

Crux Biomedical commences enrollment in Retrieve 2 pivotal U.S. IDE trial of new Vena Cava Filter

Debate over the ill effects of wind turbines on health

Children see more fast food TV ads and fewer sweets and beverage ads: Study

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News